CARGO Therapeutics’ Post

Date/time: Wednesday, March 13 at 6pm CENTRAL   Registration link:  https://lnkd.in/eU7esi2C   Hosted by: University of Buffalo (Linda Harris) University of Texas (Mitchel Cox)   Articles: Comparison of clinical outcomes among patients with isolated axial vs muscular calf vein thrombosis: A systematic review and meta-analysis https://lnkd.in/eBityJkV   Safety and learning curve of percutaneous axillary artery access for complex endovascular aortic procedures https://lnkd.in/eVWa4j9G

We’re excited to share that we will be attending AANEM (American Association of Neuromuscular and Electrodiagnostic Medicine) this year! This annual meeting will explore various topics in neuromusuclar and electrodiagnostic medicine through education, collaboration, and research. Please let us know if you will be attending - we’d love to connect while we are there! #AANEM #Neuromuscularmedicine #electrodiagnosticmedicine #patientoutcomes 

Today we’ve crossed an exciting milestone with the first scientific publication of our clinical data supporting the therapeutic potential of #senolytics in providing long-lasting, disease-modifying intervention in vision loss.     Published in the Nature Medicine journal, the research provides mechanistic evidence that eliminating #senescent cells in the retina can potentially treat and reverse the hallmarks of #DME, an approach that UNITY is clinically investigating with the senolytic candidate #UBX1325.     We are honored to contribute to the growing field of senolytic research and bring us one step closer to providing new therapies for patients living with DME. #ReimagineAging    Read more: https://bit.ly/3SqYcjT

Thanks Medical Laboratory Observer for the feature on our GloCyte® Automated Cell Counter for CSF! The article highlights an observational study at Loyola University Medical Center, “Reducing cell count bias with the GloCyte Automated Cell Counter for Cerebrospinal Fluid (CSF),” which was presented earlier this month at #ADLM2024. The findings demonstrate that GloCyte reduces subjectivity and non-random errors associated with manual counting methods, and increases diagnostic reliability for serious neurological conditions. •  Download the Study here ➡ https://lnkd.in/eDAVvB6Z •  Read the article on MLO here ➡ https://lnkd.in/eJaDxESD •  Learn more about GloCyte here ➡ https://lnkd.in/eHcQVrfu

"Saluda Medical has been on a journey to transform neuromodulation and solve large unmet clinical and health economic needs. The evidence presented at NANS demonstrates SmartLoop's capability to provide long-term superior outcomes for patients as well as advance SCS therapy efficiencies for clinical practices." Contact me for more info on how you can transform your practice with EVOKE from Saluda Medical!

97% of clinicians who have graduated from Applying Functional Medicine in Clinical Practice (AFMCP) say that the program improved their ability to provide patient-centered care. AFMCP integrates the latest medical research with a model of care that accounts for each patient’s individual history, unique genetic makeup, and environmental and lifestyle factors. If you would like to learn how to design effective, personalized treatments for every patient you see, join our upcoming AFMCP cohort. Learn more here: https://hubs.la/Q02sLkHt0

I’m an AFMPC clinician (I graduated in 2016). My greatest passion is my children and connection to my vitality. My second greatest passion is using science-backed strategies I learned at IFM to help women reconnect to their vitality. And while yes, the disconnect can often result in reproductive issues, gut issues, mental health issues, immune issues, etc.. The most common complaints by my patients are: 1. feeling “out of whack”. 2. knowing something is wrong but feeling like their GP does not take them seriously. I offer a 30 min consult if you’d like to know how a Functional Medicine-trained acupuncturist can help reframe your connection to your health and vitality. Click the link below⬇️ https://lnkd.in/gcsE8WuY

Just hours ago, a paper detailing the two-year follow-up results of our Phase 1 clinical trial featuring CYP-001, our innovative Cymerus™ off-the-shelf iPSC-derived MSC product, was published in the prestigious Nature Medicine journal. This is the second paper published in Nature Medicine regarding this trial which reports survival rate compares very favourably to previously reported outcomes in SR-aGvHD - 60% vs. historical prognosis of below 20% two-year overall survival rate. “The publication of a second paper on this trial in such a high-impact journal is a testament to the importance of this project to the wider field of cellular therapy,” John Rasko AO, the international coordinating Principal Investigator for the trial. Read the full announcement here: https://bit.ly/3IhTz71 #stemcells #innovation #aGvHD #NatureMedicine #newsalert

What were the main scientific highlights and key learnings from #EuroPCR 2024, and what should you know about impact on practice? In this short session replay, Davide Capodanno summarises his key takeaways from this year's Course ➡ https://lnkd.in/d5XsMnQW (open access). Nieves Gonzalo Nicolas Dumonteil Thomas Cuisset #interventionalcardiology #clinicaltrials #latebreakingscience #trialupdates

What an informative discussion on #HoLEP. Glad Richard Wolf Medical Instruments Corporation can help spread the word on this effective procedure for #BPH. #urology #urosome